Guideline or statement
Atrial cardiomyopathy revisited—evolution of a concept: a clinical consensus statement of the European Heart Rhythm Association (EHRA) of the ESC, the Heart Rhythm Society (HRS), the Asian Pacific Heart Rhythm Society (APHRS), and the Latin American Heart Rhythm Society (LAHRS)
- Clinical consensus statement
Recommendations
As issued by the authors
Simple atrial cardiomyopathy (AtCM) staging system (AtCM stages 1-3) integrating biomarkers, atrial geometry and electrophysiological changes; needs clinical validation
AtCM might serve as a substrate for atrial fibrillation (AF) and AF may accelerate AtCM substantially, but AtCM per se needs to be viewed as a separate entity
Original publication
Atrial cardiomyopathy revisited—evolution of a concept: a clinical consensus statement of the European Heart Rhythm Association (EHRA) of the ESC, the Heart Rhythm Society (HRS), the Asian Pacific Heart Rhythm Society (APHRS), and the Latin American Heart Rhythm Society (LAHRS). Europace. Published 30 July 2024. doi:10.1093/europace/euae204
Summarised from the published abstract; every number is checked against it